Greg Bass is an experienced professional in the pharmaceutical industry, currently serving as the Head of Market Access at Corium since 2025. Prior to this role, Greg held several senior positions including Executive Vice President of Global Market Access at both Valinor Pharma and Novos Growth Partners from 2023 to 2025 and 2018 to 2023, respectively. In earlier roles, Greg served as Executive Vice President and Chief Commercial Officer at Lipocine Inc. and Vice President of Managed Markets at Merz Therapeutics. Greg's extensive career includes various leadership roles at Janssen Biotech and experience in sales and management at Warner Chilcott and Pfizer. Greg holds a Bachelor's Degree in Biology from Brandeis University.
This person is not in any teams
This person is not in any offices